Concepedia

Atsuko Ogino

AO

Statistics

Publications

17

Citations

2.1K

H-Index

16

Active since

2005

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Okayama University

Brigham and Women's Hospital

Okayama University Hospital

Atsuko Ogino is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2005–2025

17

Publications

17

A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors

Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino et al. · Cancer Research · 2011 · 601 citations · Full text

, , +15

Clinical, Pathologic, and Biologic Features Associated with <i>BRAF</i> Mutations in Non–Small Cell Lung Cancer

Stephanie Cardarella, Atsuko Ogino, Mizuki Nishino et al. · Clinical Cancer Research · 2013 · 371 citations · Full text

, , +17

Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i> -Mutant Lung Cancer

Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin et al. · Cancer Discovery · 2015 · 219 citations · Full text

, , +17

Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non–Small Cell Lung Cancer Cell Line

Atsuko Ogino, Hiroyuki Kitao, Seiki Hirano et al. · Cancer Research · 2007 · 196 citations · Full text

, , +15

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 161 citations · Full text

, , +15

1–5 of 17